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level of these booklets was grade 8 using the Flesch-
Kincaid scale (range, grade 8-9) and grade 11 using the
SMOG scale (range, grade 11-12). Their mean word-to-
content ratio was 68:1.
Comment. The findings of this study reveal that pa-
tients prescribed warfarin are very likely to receive in-
formation sheets from community pharmacies that con-
tain only 63% of the content important for its safe use as
well as statements that experts believe are misleading or
incorrect. Comprehension of these sheets is also limited
by a reading level approximately 5 or 6 grade levels above
that recommended for health information.4 The read-
ability results found in this study are consistent with pre-
vious research reviewing drug-related patient education
brochures,5 where the mean reading level was grade 11.
In a study of warfarin therapy, more than half of pa-
tients were unable to comprehend health-related words
at levels beyond grade 8,6 and an increased risk of bleed-
ing and nonadherence has been reported in patients with
low literacy.7,8
The major limitation of this study is the absence of a
gold standard for content of warfarin information; how-
ever, we relied on consensus from experts to create a ref-
erence standard. Although we reviewed PES distributed
by Ontario pharmacies, the results are likely generaliz-
able, since many community pharmacies across the coun-
try use information sheets obtained from the same small
number of drug information databases. Since the drug
information programs were produced by 5 different
American and European software companies, our find-
ings likely apply to warfarin PES at least across North
America.
Appropriate and accurate information about warfa-
rin is critical in helping patients make educated health
care decisions. We suggest that standardization of the con-
tent of patient information about warfarin, developed with
input from anticoagulation specialists and presented in
a manner that is understandable by the majority of pa-
tients taking this medication, is an important patient safety
priority. This approach to patient education must also
be considered for other high-risk medications including
the new oral anticoagulants and other medications with
a narrow therapeutic index.
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INVITED COMMENTARY
Left Behind: Ensuring Clarity
and Completeness of Our Educational
Materials and Messages
S ometimes it seems that despite our best efforts toeducate patients and families, we miss the mark.During internship, one of us (D.A.D.) sat down
with the mom of a 2-year-old child to discuss the child’s
condition and plan for care. After spending time “clearly”
explaining things to her, the mom looked up with a be-
wildered yet calm look and said, “I have no idea what
you just said.” This mom was lost. Thankfully, she had
the courage to speak up. Often, we assume that we speak
and write clearly and that our communication is effec-
tive; yet for various reasons, there is a gap between what
patients know and what health care providers think they
should know.
Failure to consider the literacy levels and learning needs
of patients when designing educational messages is one
way in which we leave our patients behind. An article
by Diamantouros and colleagues1 assessed the accu-
racy, completeness, and reading level of 5 warfarin edu-
cation materials provided by community pharmacies or
pharmaceutical producers of warfarin. To do this assess-
ment, the authors identified 50 “essential” or “impor-
tant” knowledge elements (defined by clinical experts in
warfarin management) and used tools to assess the read-
ing level of the written materials. They found that the
information contained between 22% and 81% of essen-
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tial or important knowledge items. In addition, the read-
ing levels of the patient education sheets ranged from 7.7
to 12.5 (several grade levels higher than the recom-
mended sixth grade or below reading level).2 The authors
concluded that the patient information about warfarin had
inadequate content coverage and was not understandable
by the majority of patients taking the medication.
The article also raises the question of how much in-
formation is too much. An expert panel of thrombosis
health professionals selected 50 items that they rated as
“essential” or “important” for patients to know about war-
farin. Although most of us would agree that warfarin is
a dangerous medication if not used appropriately, are there
really 50 essential and important things for patients to
know? The design of patient education materials should
move beyond comprehensiveness to consider how much
a patient will actually read and retain. From this per-
spective, an optimal design may not include all 50 ele-
ments, particularly if they do not help a patient with daily
self-management tasks. After all, it takes more effort to
identify and distill information to the most relevant and
digestible elements than to create a comprehensive tome.
The more complex our messages, regardless of the lit-
eracy level at which they are written or the eloquence with
which they are spoken, the less people will absorb and
the more disinterested they become.3
Determining what information should be included in
educational materials for warfarin and other potentially
harmful medications should be a collaborative and it-
erative process between health professionals and pa-
tients. Most patient education materials try to commu-
nicate many concepts, instead of focusing on the 2 to 3
concepts recommended for individuals with low lit-
eracy.4 It may be particularly challenging for experts to
identify the most salient information because they rec-
ognize the nuances that others may not. However, the
nuances are not always important. (When was the last
time knowing that insulin is made in the pancreas helped
a patient manage their diabetes?) Patients can provide
valuable input into the process of selecting concepts of
most relevance to them and suggesting ways to ensure
that the messages are easily understandable.5 Omitting
patients from content development for educational ma-
terials, articulating research questions, developing in-
tervention strategies, or providing input into clinical care
processes implies that health professionals are the sole
holders of wisdom and that patients either do not pos-
sess or are unwilling to provide such knowledge.6 Not
only is this untrue, but this stance runs the risk of dis-
empowering patients, alienating them from care en-
tirely, or increasing their risk of “nonadherence.”
Optimal design of patient educational materials must
also move beyond “formulas” used in readability assess-
ment tools such as the Flesch-Kincaid and the SMOG.
The score for these formulas generally incorporates the
total number of words per sentence and syllables per
word and indicates the reading level required for a par-
ticular text. To be clear, we are not saying that such
tools should be avoided. On the contrary, developing
patient education materials at a low reading level is nec-
essary but not sufficient to improve comprehension. For
example, patient education materials designed to edu-
cate people about coronary heart disease, might substi-
tute the word “plaque” for the word “atherosclerosis” to
obtain a more favorable readability score. However, such
a change would do little to improve a patient’s under-
standing of this disease. Using the phrase “blocked arter-
ies” may result in a higher readability score and is
clearer and more meaningful to patients. We should
place more emphasis on learning good techniques for
message design and get patient input rather than simply
following readability formulas.
Patient engagement is a key component of patient- and
family-centered care, and patient-centered communica-
tion is a key quality indicator.7 Diamantouros and col-
leagues1 offer another example of how we fail to provide
patients with information they need to succeed. If we in-
tend to move toward a more patient-centered health care
system, we must engage patients in the design of our mes-
sages and have them teach us what is most valuable and
understandable. Individuals with the highest preva-
lence of chronic illnesses and those with the greatest need
for health care (eg, older adults, racial/ethnic minori-
ties, the poor, and those with low education) also are the
least able to read and comprehend information that they
need to successfully manage their health conditions.8
Knowledge and education are valuable resources that are
not equally available or accessible to all.9 Efforts to en-
sure relevant, literacy-sensitive educational messages to
those who will use them may also have the added ben-
efit of furthering the goal of achieving health equity, leav-
ing no one behind.
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Correspondence: Dr Cené, Division of General Internal
Medicine, University of North Carolina at Chapel Hill,
5039 Old Clinic Bldg, CB#7110, Chapel Hill, NC 27599-
7110 (crystal_cene@med.unc.edu).
Conflict of Interest Disclosures: None reported.
1. Diamantouros A, Bartle W, Geerts W. Patient information about warfarin: an
assessment of accuracy and readability [published online February 25, 2013].
JAMA Intern Med. 2013;173(7):582-583.
2. Weiss BD, Coyne C. Communicating with patients who cannot read. N Engl
J Med. 1997;337(4):272-274.
3. Stableford S, Mettger W. Plain language: a strategic response to the health
literacy challenge. J Public Health Policy. 2007;28(1):71-93.
4. Doak CC. Teaching Patients With Low Literacy Skills. Philadelphia, PA: J.B.
Lippincott; 1996.
5. Seligman HK, Wallace AS, DeWalt DA, et al. Facilitating behavior change with
low-literacy patient education materials. Am J Health Behav. 2007;31(suppl
1):S69-S78.
6. Kendall E, Ehrlich C, Sunderland N, Muenchberger H, Rushton C. Self-
managing versus self-management: reinvigorating the socio-political dimen-
sions of self-management. Chronic Illn. 2011;7(1):87-98.
7. Committee on Quality of Health Care in America, Institute of Medicine.
Crossing the Quality Chasm: A New Health System for the 21st Century. Wash-
ington, DC: National Academy Press; 2001.
8. Williams MV, Parker RM, Baker DW, et al. Inadequate functional health lit-
eracy among patients at two public hospitals. JAMA. 1995;274(21):1677-1682.
9. Furler J, Harris M, Rogers A. Equity and long-term condition self-management.
Chronic Illn. 2011;7(1):3-5.
Crystal Wiley Cené, MD, MPH
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